Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer

por Rice, Meghan A., Malhotra, Sanjay V., Stoyanova, Tanya
Publicado 2019

Oncogene-mediated metabolic gene signature predicts breast cancer outcome

por Aslan, Merve, Hsu, En-Chi, Garcia-Marques, Fernando J., Bermudez, Abel, Liu, Shiqin, Shen, Michelle, West, Meredith, Zhang, Chiyuan Amy, Rice, Meghan A., Brooks, James D., West, Robert, Pitteri, Sharon J., Győrffy, Balázs, Stoyanova, Tanya
Publicado 2021

Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer

por Liu, Shiqin, Shen, Michelle, Hsu, En-Chi, Zhang, Chiyuan Amy, Garcia-Marques, Fernando, Nolley, Rosalie, Koul, Kashyap, Rice, Meghan A., Aslan, Merve, Pitteri, Sharon J., Massie, Charlie, George, Anne, Brooks, James D., Gnanapragasam, Vincent J., Stoyanova, Tanya
Publicado 2020

Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1

por Hsu, En-Chi, Rice, Meghan A., Bermudez, Abel, Marques, Fernando Jose Garcia, Aslan, Merve, Liu, Shiqin, Ghoochani, Ali, Zhang, Chiyuan Amy, Chen, Yun-Sheng, Zlitni, Aimen, Kumar, Sahil, Nolley, Rosalie, Habte, Frezghi, Shen, Michelle, Koul, Kashyap, Peehl, Donna M., Zoubeidi, Amina, Gambhir, Sanjiv S., Kunder, Christian A., Pitteri, Sharon J., Brooks, James D., Stoyanova, Tanya
Publicado 2020

SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer

por Rice, Meghan A., Kumar, Vineet, Tailor, Dhanir, Garcia-Marques, Fernando Jose, Hsu, En-Chi, Liu, Shiqin, Bermudez, Abel, Kanchustambham, Vijayalakshmi, Shankar, Vishnu, Inde, Zintis, Alabi, Busola Ruth, Muruganantham, Arvind, Shen, Michelle, Pandrala, Mallesh, Nolley, Rosalie, Aslan, Merve, Ghoochani, Ali, Agarwal, Arushi, Buckup, Mark, Kumar, Manoj, Going, Catherine C., Peehl, Donna M., Dixon, Scott J., Zare, Richard N., Brooks, James D., Pitteri, Sharon J., Malhotra, Sanjay V., Stoyanova, Tanya
Publicado 2022